Skip to main content
Advertisement
Advertisement

SNY

SNY logo

Sanofi - ADR

42.77
USD
Sponsored
+0.05
+0.12%
Sep 11, 15:59 UTC -4
Closed
exchange

Pre-Market

43.32

+0.55
+1.29%

SNY Earnings Reports

Positive Surprise Ratio

SNY beat 33 of 42 last estimates.

79%

Next Report

Date of Next Report
Oct 30, 2026
Estimate for Q3 26 (Revenue/ EPS)
$13.68B
/
$2.86
Implied change from Q2 26 (Revenue/ EPS)
+17.98%
/
+36.84%
Implied change from Q3 25 (Revenue/ EPS)
+10.04%
/
-1.72%

Sanofi - ADR earnings per share and revenue

On Jul 30, 2026, SNY reported earnings of 2.09 USD per share (EPS) for Q2 26, beating the estimate of 1.91 USD, resulting in a 8.91% surprise. Revenue reached 11.60 billion, compared to an expected 11.33 billion, with a 2.32% difference. The market reacted with a -4.37% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of 2.86 USD, with revenue projected to reach 13.68 billion USD, implying an increase of 36.84% EPS, and increase of 17.98% in Revenue from the last quarter.
FAQ
For Q2 2026, Sanofi - ADR reported EPS of $2.09, beating estimates by 8.91%, and revenue of $11.60B, 2.32% above expectations.
The stock price moved down -4.37%, changed from $44.85 before the earnings release to $42.89 the day after.
The next earning report is scheduled for Oct 30, 2026.
Based on 3 analysts, Sanofi - ADR is expected to report EPS of $2.86 and revenue of $13.68B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement